Rep. Lisa C. McClain Buys GSK PLC Sponsored ADR (NYSE:GSK) Shares

Key Points

• Representative Lisa C. McClain purchased shares of GSK PLC for between $1,001 and $15,000 on June 17th, according to a filing dated August 13th.
• GSK reported an earnings per share (EPS) of $1.23 for the last quarter, surpassing analysts' expectations and indicating a revenue growth of 1.3% year-over-year.
• The pharmaceutical company has announced a quarterly dividend of $0.4206 per share, reflecting an annualized yield of 4.2% and a payout ratio of 77.78%.

Representative Lisa C. McClain (R-Michigan) recently bought shares of GSK PLC Sponsored ADR NYSE: GSK. In a filing disclosed on August 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in GSK stock on June 17th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
• Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Waters NYSE: WAT on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.

GSK Price Performance

NYSE:GSK traded down $0.5050 during trading hours on Monday, reaching $39.6850. The company had a trading volume of 1,078,900 shares, compared to its average volume of 5,135,313. The stock has a 50-day moving average of $38.34 and a two-hundred day moving average of $38.13. The company has a quick ratio of 0.57, a current ratio of 0.87 and a debt-to-equity ratio of 1.07. The firm has a market capitalization of $80.87 billion, a PE ratio of 18.38, a PEG ratio of 1.74 and a beta of 0.51. GSK PLC Sponsored ADR has a one year low of $31.72 and a one year high of $44.67.

GSK (NYSE:GSK - Get Free Report) last announced its earnings results on Wednesday, July 30th. The pharmaceutical company reported $1.23 EPS for the quarter, topping the consensus estimate of $1.12 by $0.11. GSK had a return on equity of 49.22% and a net margin of 10.81%.The company had revenue of $10.64 billion for the quarter, compared to analysts' expectations of $7.92 billion. During the same quarter in the prior year, the business earned $0.43 earnings per share. The business's revenue for the quarter was up 1.3% on a year-over-year basis. GSK has set its FY 2025 guidance at 4.590-4.590 EPS. Analysts forecast that GSK PLC Sponsored ADR will post 4.14 earnings per share for the current year.

GSK Cuts Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 9th. Shareholders of record on Friday, August 15th will be given a $0.4206 dividend. This represents a $1.68 dividend on an annualized basis and a yield of 4.2%. The ex-dividend date is Friday, August 15th. GSK's dividend payout ratio is 77.78%.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. Wall Street Zen raised shares of GSK from a "hold" rating to a "buy" rating in a report on Sunday, August 3rd. Hsbc Global Res raised shares of GSK to a "strong sell" rating in a report on Monday, April 28th. Finally, Berenberg Bank reiterated a "hold" rating on shares of GSK in a report on Tuesday, June 3rd. Seven research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Reduce" and an average price target of $37.38.

Hedge Funds Weigh In On GSK

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Brighton Jones LLC bought a new position in GSK during the fourth quarter worth about $528,000. First Hawaiian Bank boosted its holdings in GSK by 18.8% during the first quarter. First Hawaiian Bank now owns 101,039 shares of the pharmaceutical company's stock worth $3,914,000 after buying an additional 15,987 shares during the last quarter. Forum Financial Management LP boosted its holdings in GSK by 167.9% during the fourth quarter. Forum Financial Management LP now owns 13,397 shares of the pharmaceutical company's stock worth $453,000 after buying an additional 8,396 shares during the last quarter. Barclays PLC boosted its holdings in GSK by 84.2% during the fourth quarter. Barclays PLC now owns 49,628 shares of the pharmaceutical company's stock worth $1,678,000 after buying an additional 22,689 shares during the last quarter. Finally, Crestline Management LP bought a new position in GSK during the fourth quarter worth about $1,047,000. Institutional investors own 15.74% of the company's stock.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.